Kidswell Bio Corporation (TYO:4584)
Japan
· Delayed Price · Currency is JPY 251.00
-28.00 (-10.04%)
Jul 1, 2025, 3:30 PM JST
Kidswell Bio Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2015 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2015 - 2018 |
Cash & Equivalents | 2,995 | 1,187 | 1,461 | 2,032 | 2,009 | Upgrade
|
Cash & Short-Term Investments | 2,995 | 1,187 | 1,461 | 2,032 | 2,009 | Upgrade
|
Cash Growth | 152.32% | -18.75% | -28.10% | 1.13% | 6.25% | Upgrade
|
Accounts Receivable | 1,267 | 461 | 816 | 651 | 559.26 | Upgrade
|
Other Receivables | 50 | - | - | - | - | Upgrade
|
Receivables | 1,317 | 461 | 816 | 651 | 559.26 | Upgrade
|
Inventory | 1,475 | 988 | 450 | 254 | 11.93 | Upgrade
|
Prepaid Expenses | 16 | - | - | - | 14.67 | Upgrade
|
Other Current Assets | 897 | 689 | 619 | 385 | 226.49 | Upgrade
|
Total Current Assets | 6,700 | 3,325 | 3,346 | 3,322 | 2,822 | Upgrade
|
Property, Plant & Equipment | 1 | 1 | 3 | 1 | 1.1 | Upgrade
|
Long-Term Investments | 305 | 172 | 581 | 267 | 322.57 | Upgrade
|
Other Intangible Assets | - | 3 | 2 | - | 0.1 | Upgrade
|
Other Long-Term Assets | 2 | 2 | 1 | 2 | 5.88 | Upgrade
|
Total Assets | 7,008 | 3,503 | 3,933 | 3,592 | 3,151 | Upgrade
|
Accounts Payable | 226 | 45 | 109 | 8 | 56.74 | Upgrade
|
Accrued Expenses | - | - | - | - | 319.06 | Upgrade
|
Short-Term Debt | - | - | - | 25 | - | Upgrade
|
Current Portion of Long-Term Debt | 657 | 75 | - | - | - | Upgrade
|
Current Income Taxes Payable | 453 | 297 | 396 | 255 | 22.53 | Upgrade
|
Other Current Liabilities | 2,982 | 711 | 609 | 592 | 1.83 | Upgrade
|
Total Current Liabilities | 4,318 | 1,128 | 1,114 | 880 | 400.16 | Upgrade
|
Long-Term Debt | 1,180 | 625 | 1,100 | 1,200 | - | Upgrade
|
Long-Term Deferred Tax Liabilities | 56 | - | 89 | - | 0.7 | Upgrade
|
Other Long-Term Liabilities | 4 | 2 | 2 | 6 | 0 | Upgrade
|
Total Liabilities | 5,599 | 1,786 | 2,324 | 2,105 | 420.09 | Upgrade
|
Common Stock | 2,317 | 1,421 | 1,032 | 611 | 591.34 | Upgrade
|
Additional Paid-In Capital | 11,623 | 10,726 | 10,337 | 9,917 | 3,864 | Upgrade
|
Retained Earnings | -12,730 | -10,613 | -10,078 | -9,077 | -1,761 | Upgrade
|
Comprehensive Income & Other | 199 | 183 | 318 | 36 | 36.46 | Upgrade
|
Shareholders' Equity | 1,409 | 1,717 | 1,609 | 1,487 | 2,731 | Upgrade
|
Total Liabilities & Equity | 7,008 | 3,503 | 3,933 | 3,592 | 3,151 | Upgrade
|
Total Debt | 1,837 | 700 | 1,100 | 1,225 | - | Upgrade
|
Net Cash (Debt) | 1,158 | 487 | 361 | 807 | 2,009 | Upgrade
|
Net Cash Growth | 137.78% | 34.90% | -55.27% | -59.84% | 6.25% | Upgrade
|
Net Cash Per Share | 28.59 | 15.79 | 12.54 | 29.19 | 102.88 | Upgrade
|
Filing Date Shares Outstanding | 43.88 | 31.44 | 29.94 | 28.73 | 20.34 | Upgrade
|
Total Common Shares Outstanding | 43.88 | 31.44 | 29.62 | 27.65 | 20.34 | Upgrade
|
Working Capital | 2,382 | 2,197 | 2,232 | 2,442 | 2,422 | Upgrade
|
Book Value Per Share | 32.11 | 54.62 | 54.32 | 53.79 | 134.26 | Upgrade
|
Tangible Book Value | 1,409 | 1,714 | 1,607 | 1,487 | 2,731 | Upgrade
|
Tangible Book Value Per Share | 32.11 | 54.52 | 54.25 | 53.79 | 134.26 | Upgrade
|
Buildings | - | - | - | - | 2.05 | Upgrade
|
Machinery | - | - | - | - | 4.99 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.